Emanuela Messina

Dec 7, 2023 | thelancet.com | Martina Bottanelli |Vita-Salute San Raffaele |Emanuela Messina |Angelo Roberto Raccagni

In a recent study in The Lancet Infectious Diseases, Nicolò Moschetta and colleagues compared the neutralising antibody response of individuals at 6 months after mpox (formerly known as monkeypox) infection or Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN) vaccination, finding that people receiving vaccination had lower concentrations of mpox neutralising antibodies than individuals with mpox infection. 1Moschetta N Raccagni AR Bianchi M et al.